Clint T Allen

Associate Professor

20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Clint T Allen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • Neoadjuvant PD-1 immune checkpoint blockade reverses functional immunodominance among tumor antigen–specific T cells

    Friedman, J., Moore, E. C., Zolkind, P., Robbins, Y., Clavijo, P. E., Sun, L., Greene, S., Morisada, M. V., Mydlarz, W. K., Schmitt, N., Hodge, J. W., Schreiber, H., van Waes, C., Uppaluri, R. & Allen, C., Feb 1 2020, In : Clinical Cancer Research. 26, 3, p. 679-689 11 p.

    Research output: Contribution to journalArticle

  • Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells

    Friedman, J., Padget, M., Lee, J., Schlom, J., Hodge, J. & Allen, C. T., Mar 1 2019, In : Oral Oncology. 90, p. 38-44 7 p.

    Research output: Contribution to journalArticle

  • Dual antagonist of cIAP/XIAP ASTX660 sensitizes HPV- and HPV+ head and neck cancers to TNFα, TRAIL, and radiation therapy

    Xiao, R., An, Y., Ye, W., Derakhshan, A., Cheng, H., Yang, X., Allen, C., Chen, Z., Schmitt, N. C. & Van Waes, C., Nov 1 2019, In : Clinical Cancer Research. 25, 21, p. 6463-6474 12 p.

    Research output: Contribution to journalArticle

  • Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition

    Patel, P., Sun, L., Robbins, Y., Clavijo, P. E., Friedman, J., Silvin, C., Van Waes, C., Cook, J., Mitchell, J. & Allen, C., Nov 2 2019, In : OncoImmunology. 8, 11, e1638207.

    Research output: Contribution to journalArticle